PLoS ONE (Jan 2017)

Correction: Natalizumab stabilizes physical, cognitive, MRI, and OCT markers of disease activity: A prospective, non-randomized pilot study.

  • Garrick D Talmage,
  • Oscar J M Coppes,
  • Adil Javed,
  • Jacqueline Bernard

DOI
https://doi.org/10.1371/journal.pone.0178338
Journal volume & issue
Vol. 12, no. 5
p. e0178338

Abstract

Read online

[This corrects the article DOI: 10.1371/journal.pone.0173299.].